Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Johnson & Johnson (NYSE:JNJ) will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.68 per share, down from $2.82 per share in the year-ago period. Johnson & Johnson projects to report quarterly revenue of $22.86 billion, compared to $22.45 billion a year earlier, according to data from Benzinga Pro.

On July 8, Johnson & Johnson announced the submission of a supplemental new drug application to the US FDA based upon long-term data evaluating the safety and efficacy of CAPLYTA for the prevention of relapse in schizophrenia.

Johnson & Johnson shares gained 0.9% to close at $157.69 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings ...